Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trypsin and Chymotrypsin for Mandibular Molars with Chronic Apical Abscess
NCT06164509Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2023
- Primary completion
- Sep 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of trypsin and chymotrypsin in Mandibular Abscess (3 arms), sponsored by Ain Shams University. Primary endpoint: Lesion size and bone formation at 6 months. Status: unknown.
02
Drugs
trypsinchymotrypsin
03
Conditions
Mandibular Abscess
Beyond the preview
Go deeper on NCT06164509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164509.